These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 23535871)
1. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia. Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871 [TBL] [Abstract][Full Text] [Related]
2. Role of NF-kappaB and cytokine in experimental cancer cachexia. Zhou W; Jiang ZW; Tian J; Jiang J; Li N; Li JS World J Gastroenterol; 2003 Jul; 9(7):1567-70. PubMed ID: 12854165 [TBL] [Abstract][Full Text] [Related]
3. [Role of NF-kappa B in cancer cachexia]. Zhou W; Jiang ZW; Jiang J; Li N; Li JS Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260 [TBL] [Abstract][Full Text] [Related]
4. Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1. Chen C; Ju R; Zhu L; Li J; Chen W; Zhang DC; Ye CY; Guo L Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):423-433. PubMed ID: 28124088 [TBL] [Abstract][Full Text] [Related]
5. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype. Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness. Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622 [TBL] [Abstract][Full Text] [Related]
7. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia. Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133 [TBL] [Abstract][Full Text] [Related]
8. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation. Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525 [TBL] [Abstract][Full Text] [Related]
9. L-carnitine ameliorates cancer cachexia in mice by regulating the expression and activity of carnitine palmityl transferase. Liu S; Wu HJ; Zhang ZQ; Chen Q; Liu B; Wu JP; Zhu L Cancer Biol Ther; 2011 Jul; 12(2):125-30. PubMed ID: 21532335 [TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexia. Vaughan VC; Sullivan-Gunn M; Hinch E; Martin P; Lewandowski PA PLoS One; 2012; 7(9):e45900. PubMed ID: 23029301 [TBL] [Abstract][Full Text] [Related]
11. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837 [TBL] [Abstract][Full Text] [Related]
12. Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia. Wang Q; Li C; Peng X; Kang Q; Deng D; Zhang L; Zheng Y; Wang C; Qiao Z; Guo D; You S; Tang H Med Oncol; 2015 Apr; 32(4):100. PubMed ID: 25737433 [TBL] [Abstract][Full Text] [Related]
13. [The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease]. Ma BM; Liu ZH; Liang ZK; Guan LJ; Wang XL Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):441-6. PubMed ID: 24103208 [TBL] [Abstract][Full Text] [Related]
14. Curcumin Targeting NF- Zhang J; Zheng J; Chen H; Li X; Ye C; Zhang F; Zhang Z; Yao Q; Guo Y Mediators Inflamm; 2022; 2022():2567150. PubMed ID: 35132306 [TBL] [Abstract][Full Text] [Related]
15. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer. Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877 [TBL] [Abstract][Full Text] [Related]
16. Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice. Nai YJ; Jiang ZW; Wang ZM; Li N; Li JS JPEN J Parenter Enteral Nutr; 2007; 31(1):18-25. PubMed ID: 17202436 [TBL] [Abstract][Full Text] [Related]
17. Paeonia lactiflora root extract suppresses cancer cachexia by down-regulating muscular NF-κB signalling and muscle-specific E3 ubiquitin ligases in cancer-bearing mice. Bae T; Jang J; Lee H; Song J; Chae S; Park M; Son CG; Yoon S; Yoon Y J Ethnopharmacol; 2020 Jan; 246():112222. PubMed ID: 31505213 [TBL] [Abstract][Full Text] [Related]
18. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice. Hitt A; Graves E; McCarthy DO Res Nurs Health; 2005 Feb; 28(1):56-66. PubMed ID: 15625704 [TBL] [Abstract][Full Text] [Related]
19. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
20. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model. Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]